Video Experimental Relacionado

Updated: Jul 7, 2025

Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding

Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding

Published on: June 9, 2017

Determinantes moleculares de la eficacia y potencia del ligando en la señalización GPCR

Franziska M Heydenreich^1,2,3, Maria Marti-Solano^2,4, Manbir Sandhu⁵

¹Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA.

Science (New York, N.Y.)

|December 21, 2023

Resumen

Comprender cómo los medicamentos interactúan con los receptores acoplados a proteínas G (GPCR) es clave. Este estudio revela cómo los residuos de receptores específicos traducen la información del ligando para controlar la eficacia y la potencia del fármaco, ayudando al diseño de nuevos fármacos.

Área de la Ciencia:

Farmacología
Biología estructural
La bioquímica

Sus antecedentes:

Los receptores acoplados a proteínas G (GPCR) son objetivos farmacológicos cruciales involucrados en la señalización celular.
La base molecular de cómo los ligandos determinan las propiedades de señalización de los receptores, como la eficacia y la potencia, no se comprende completamente.
Comprender estos mecanismos es vital para desarrollar terapias dirigidas.

Objetivo del estudio:

Para aclarar cómo los residuos de receptores específicos decodifican la información del ligando para modular las respuestas de señalización.
Desarrollar un marco científico de datos para integrar datos farmacológicos y estructurales.
Para descubrir las redes alostéricas críticas para la farmacología del ligando.

Principales métodos:

Utilizó el sistema de proteínas G del receptor adrenérgico de adrenalina-β2 como modelo.
Desarrolló un marco científico de datos que combina datos farmacológicos y estructurales.
Cambios de conformación de los receptores y vías de comunicación alostéricas analizados.

Principales resultados:

Residuos de receptores específicos identificados responsables de la traducción de la información del ligando en resultados de señalización.
Se han descubierto redes alostéricas que median la activación del receptor dependiente del ligando.
Demostró un marco para analizar las interacciones ligando-receptor.

Conclusiones:

Los residuos específicos de los receptores juegan un papel crítico en la determinación de la eficacia y la potencia del fármaco.
El marco de ciencia de datos desarrollado proporciona información sobre la señalización ligando-receptor.
Este enfoque puede guiar el diseño de nuevos medicamentos con perfiles farmacológicos adaptados.

Más Videos Relacionados

Quantifying Agonist Activity at G Protein-coupled Receptors

Quantifying Agonist Activity at G Protein-coupled Receptors

Published on: December 26, 2011

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

Videos de Conceptos Relacionados

The Two-State Receptor Model

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...

GPCR Desensitization

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...

Transducer Mechanism: G Protein–Coupled Receptors

Transducer Mechanism: G Protein–Coupled Receptors

G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...

Drug-Receptor Interactions

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....

G Protein-coupled Receptors

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...

GPCRs Regulate Adenylyl Cylase Activity

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...